281 related articles for article (PubMed ID: 23885815)
1. Vaccine adjuvant safety: the elephant in the room.
Petrovsky N
Expert Rev Vaccines; 2013 Jul; 12(7):715-7. PubMed ID: 23885815
[No Abstract] [Full Text] [Related]
2. IABS international scientific workshop--Mode of Action of Adjuvants: implications for vaccine safety and design, April 29-30, 2010, Bethesda, MD, USA.
Seemann S; Dodet B
Vaccine; 2011 Apr; 29(17):3340. PubMed ID: 21335035
[No Abstract] [Full Text] [Related]
3. When an aluminium adjuvant is not an aluminium adjuvant used in human vaccination programmes.
Exley C
Vaccine; 2012 Mar; 30(12):2042. PubMed ID: 22041301
[No Abstract] [Full Text] [Related]
4. TLR-based immune adjuvants.
Steinhagen F; Kinjo T; Bode C; Klinman DM
Vaccine; 2011 Apr; 29(17):3341-55. PubMed ID: 20713100
[TBL] [Abstract][Full Text] [Related]
5. Novel vaccines and adjuvant systems: the utility of animal models for predicting immunogenicity in humans.
Davis HL
Hum Vaccin; 2008; 4(3):246-50. PubMed ID: 18382138
[TBL] [Abstract][Full Text] [Related]
6. The path to a successful vaccine adjuvant--'the long and winding road'.
O'Hagan DT; De Gregorio E
Drug Discov Today; 2009 Jun; 14(11-12):541-51. PubMed ID: 19508916
[TBL] [Abstract][Full Text] [Related]
7. New developments in nanoparticle-based vaccination.
Riedmann EM
Hum Vaccin Immunother; 2013 Dec; 9(12):2502. PubMed ID: 24716209
[No Abstract] [Full Text] [Related]
8. New adjuvanted vaccines in pregnancy: what is known about their safety?
Herberts C; Melgert B; van der Laan JW; Faas M
Expert Rev Vaccines; 2010 Dec; 9(12):1411-22. PubMed ID: 21105777
[TBL] [Abstract][Full Text] [Related]
9. Vaccine adjuvants.
Reed SG
Expert Rev Vaccines; 2013 Jul; 12(7):705-6. PubMed ID: 23885812
[No Abstract] [Full Text] [Related]
10. Are we entering a new age for human vaccine adjuvants?
O'Hagan DT; Fox CB
Expert Rev Vaccines; 2015 Jul; 14(7):909-11. PubMed ID: 25947042
[TBL] [Abstract][Full Text] [Related]
11. Vaccine adjuvants: smart components to boost the immune system.
Bastola R; Noh G; Keum T; Bashyal S; Seo JE; Choi J; Oh Y; Cho Y; Lee S
Arch Pharm Res; 2017 Nov; 40(11):1238-1248. PubMed ID: 29027637
[TBL] [Abstract][Full Text] [Related]
12. TLR4 agonists as vaccine adjuvants: a chemist's perspective.
Johnson DA
Expert Rev Vaccines; 2013 Jul; 12(7):711-3. PubMed ID: 23885814
[No Abstract] [Full Text] [Related]
13. Vaccines for the elderly.
Weinberger B; Grubeck-Loebenstein B
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():100-8. PubMed ID: 22862783
[TBL] [Abstract][Full Text] [Related]
14. Vaccine adjuvants.
Glenn G
Expert Rev Vaccines; 2003 Apr; 2(2):163-4. PubMed ID: 12899568
[No Abstract] [Full Text] [Related]
15. Vaccination of immunocompromised patients.
Ljungman P
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():93-9. PubMed ID: 23051059
[TBL] [Abstract][Full Text] [Related]
16. New insights in mucosal vaccine development.
Pavot V; Rochereau N; Genin C; Verrier B; Paul S
Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
[TBL] [Abstract][Full Text] [Related]
17. Systemic immunotoxicity reactions induced by adjuvanted vaccines.
Batista-Duharte A; Portuondo D; Pérez O; Carlos IZ
Int Immunopharmacol; 2014 May; 20(1):170-80. PubMed ID: 24607449
[TBL] [Abstract][Full Text] [Related]
18. Survey of human-use adjuvants.
Kenney RT; Edelman R
Expert Rev Vaccines; 2003 Apr; 2(2):167-88. PubMed ID: 12899569
[TBL] [Abstract][Full Text] [Related]
19. Vaccine adjuvants.
Macy DW
Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):206-11. PubMed ID: 9283246
[TBL] [Abstract][Full Text] [Related]
20. Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature.
Herzog C
Expert Rev Vaccines; 2014 Mar; 13(3):399-415. PubMed ID: 24512188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
